AOXG
vs
S&P 500
AOXG
S&P 500
Over the past 12 months, AOXG has underperformed S&P 500, delivering a return of -37% compared to the S&P 500's +14% growth.
Stocks Performance
AOXG vs S&P 500
Performance Gap
AOXG vs S&P 500
Performance By Year
AOXG vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Aoxing Pharmaceutical Company Inc
Glance View
Aoxing Pharmaceutical Co., Inc. engages in the research, development, manufacture, and distribution of a variety of narcotics and pain management products. The company is headquartered in Foster City, California. The company went IPO on 2002-05-28. The firm holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.